The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Embryonal Carcinoma: Treatment of Aggressive Non-Seminomatous Germ Cell Tumor

Risk-stratified chemotherapy and surgical management for embryonal carcinoma component of testicular and extragonadal germ cell tumors

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Embryonal Carcinoma: Treatment of Aggressive Non-Seminomatous Germ Cell Tumor?

Embryonal carcinoma is aggressive non-seminomatous germ cell tumor with primitive epithelial differentiation.

Pure embryonal carcinoma is rare with most tumors containing mixed germ cell components.

Tumor markers including alpha-fetoprotein and beta-hCG guide diagnosis with non-elevated markers in pure embryonal.

Predominantly embryonal histology in stage I disease carries higher relapse risk during surveillance.

Treatment follows non-seminomatous germ cell tumor protocols with risk-stratified approach.

Symptoms

Painless testicular mass represents most common presentation often discovered incidentally.
Back pain, abdominal mass, weight loss suggest advanced retroperitoneal disease.
Pulmonary symptoms including dyspnea, cough, hemoptysis suggest pulmonary metastases.
Gynecomastia from beta-hCG elevation in mixed tumors with choriocarcinomatous component.
Constitutional symptoms including fatigue, weight loss may accompany advanced disease.

Risk Factors

Cryptorchidism is established risk factor for testicular germ cell tumors including embryonal carcinoma.
Family history of testicular cancer increases risk warranting awareness and self-examination.
Klinefelter syndrome and other genetic syndromes increase germ cell tumor risk.
Caucasian ethnicity has higher incidence compared to African American populations.
Personal history of contralateral testicular germ cell tumor increases risk in remaining testis.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Painless testicular mass warrants urgent urologic evaluation with scrotal ultrasound and tumor markers.
  • Specialized testicular cancer center referral with multidisciplinary expertise optimizes outcomes.
  • Back pain, abdominal symptoms, respiratory symptoms after orchiectomy require staging evaluation.
  • Tumor marker elevation, new lymphadenopathy or visceral lesions warrant restaging and treatment.
  • Multidisciplinary care including urology, medical oncology, radiation oncology, surgical oncology essential.

Treatment Methods

01
Radical inguinal orchiectomy with high ligation of spermatic cord represents primary surgical management.
02
Stage I management options include active surveillance, primary retroperitoneal lymph node dissection or single-cycle BEP.
03
Advanced disease BEP chemotherapy with 3-4 cycles based on IGCCC risk stratification.
04
Post-chemotherapy retroperitoneal lymph node dissection for residual masses essential.
05
Comprehensive multidisciplinary care with sperm banking before treatment, tumor marker surveillance during and after therapy, imaging surveillance per stage and treatment, fertility evaluation and counseling, cardiovascular risk monitoring for cisplatin-treated patients, salvage therapy with VIP or TIP for relapse, high-dose chemotherapy with autologous stem cell transplant for selected refractory cases, contralateral testicular surveillance for second primary, and survivorship care addressing long-term cisplatin and bleomycin toxicities provides excellent outcomes with cure rates exceeding 95% in good-risk patients with embryonal carcinoma.

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.